Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/29/18
End: 12/31/20
Due: 12/31/21
Phase: N/A
Priority: Normal
Start: 02/15/20
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 01/26/23
End: 04/30/26
Due: 04/30/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| CCCR-NK92 Cells Immunotherapy for Non-small Cell Lung Carcinoma | NCT03656705 | Xinxiang medical university | user2@example.com | None | 2018-09-29 | 2020-12-31 | 2021-12-31 | - | - | 2025-07-14 |
| NK Cells Treatment for COVID-19 | NCT04280224 | Xinxiang medical university | user2@example.com | None | 2020-02-15 | 2022-12-31 | 2023-12-31 | - | - | 2025-07-14 |
| NKG2D-CAR-NK92 Cells Immunotherapy for Solid Tumors | NCT05528341 | Xinxiang medical university | user2@example.com | None | 2023-01-26 | 2026-04-30 | 2027-04-30 | - | - | 2025-07-14 |